Stock Report

Download full stock data and analysis for free Last Updated: 28-Sep-2026

Stock Rating

Is this stock worth it? Our ratings reveal the truth.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Kiniksa Pharmaceuticals Ltd. Class A (KNSA) Peer Comparison

Stock Card factsheet share-fund-plan-icon

$75.08

up-down-arrow $-0.26 (-0.35%)

As on 25-Sep-2026 16:00EDT

Market cap

info icon

$5,858 Mln

Revenue (TTM)

info icon

$841 Mln

P/E Ratio

info icon

75.8

P/B Ratio

info icon

9.1

Div. Yield

info icon

0 %

The underlying data is unavailable.
loading...
loading...